PapersFlow Research Brief
Sarcoma Diagnosis and Treatment
Research Guide
What is Sarcoma Diagnosis and Treatment?
Sarcoma diagnosis and treatment involves histopathological classification, surgical staging, molecular profiling, and targeted therapies for rare mesenchymal tumors arising from soft tissue or bone.
The field encompasses 120,781 published works focused on diagnostic classification and therapeutic approaches for sarcomas. Key advancements include surgical staging systems and kinase-targeted treatments for specific subtypes like gastrointestinal stromal tumors (GISTs). Growth rate over the past five years is not available in the provided data.
Research Sub-Topics
Gastrointestinal Stromal Tumor Treatment
This sub-topic covers targeted therapies like imatinib and kinase inhibitors for GIST, along with surgical resection strategies. Researchers study mutation-specific responses, resistance mechanisms, and combination therapies.
Soft Tissue Sarcoma Staging Systems
This sub-topic examines histopathological grading, TNM staging, and prognostic scoring for soft tissue sarcomas. Researchers develop and validate systems to predict outcomes and guide treatment.
TRK Fusion Sarcomas
This sub-topic focuses on NTRK gene fusions in sarcomas and efficacy of TRK inhibitors like larotrectinib. Researchers investigate fusion detection methods and clinical trial outcomes.
Sarcoma Histopathological Classification
This sub-topic addresses WHO classifications and microscopic techniques for sarcoma subtyping. Researchers analyze histological features, immunohistochemistry, and molecular markers for diagnosis.
Metastatic Sarcoma Management
This sub-topic explores systemic chemotherapy, immunotherapy, and metastasectomy for advanced sarcomas. Researchers evaluate response rates, survival endpoints, and novel agents.
Why It Matters
Sarcoma diagnosis and treatment directly impacts patient outcomes through precise staging and targeted therapies, as Enneking et al. (1980) established a surgical staging system for musculoskeletal sarcoma that guides resection and prognosis ("A System for the Surgical Staging of Musculoskeletal Sarcoma"). In GISTs, DeMatteo et al. (2000) analyzed 200 cases showing tumor size predicts survival after complete resection, with intraabdominal recurrence common ("Two Hundred Gastrointestinal Stromal Tumors"). Heinrich et al. (2003) demonstrated imatinib efficacy in metastatic GIST depends on KIT or PDGFRA mutations, with 2279 citations underscoring its clinical adoption ("Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor"). Recent preprints highlight next-generation sequencing (NGS) for genomic profiling in metastatic sarcomas, where 5-year survival remains low despite advances.
Reading Guide
Where to Start
"A System for the Surgical Staging of Musculoskeletal Sarcoma" by Enneking et al. (1980) is the first read, as it provides the foundational staging framework essential for understanding sarcoma surgical management and prognosis.
Key Papers Explained
Enneking et al. (1980) 'A System for the Surgical Staging of Musculoskeletal Sarcoma' establishes staging basics, which DeMatteo et al. (2000) 'Two Hundred Gastrointestinal Stromal Tumors' applies to GIST prognosis via tumor size and resection. Heinrich et al. (2003) 'Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor' builds on this by linking mutations to targeted therapy response. Drilon et al. (2018) 'Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children' extends molecular targeting to TRK fusions across sarcomas.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints focus on NGS for genomic profiling in sarcomas, with real-world data from European institutions assessing diagnostic benefits. BC Cancer and UBC developed a single test detecting over 50 sarcoma types, accelerating diagnosis. AI projects and fast track designations like ADCE-D01 for soft tissue sarcoma signal active frontiers.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | WHO Classification of Tumours of Haematopoietic and Lymphoid T... | 2017 | Medical Entomology and... | 13.0K | ✓ |
| 2 | International Scoring System for Evaluating Prognosis in Myelo... | 1997 | Blood | 4.4K | ✓ |
| 3 | Case report 3 | 1976 | Skeletal Radiology | 4.1K | ✕ |
| 4 | Proposals for the classification of the myelodysplastic syndromes | 1982 | British Journal of Hae... | 3.7K | ✕ |
| 5 | Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancer... | 2018 | New England Journal of... | 2.6K | ✓ |
| 6 | Two Hundred Gastrointestinal Stromal Tumors | 2000 | Annals of Surgery | 2.5K | ✓ |
| 7 | A System for the Surgical Staging of Musculoskeletal Sarcoma | 1980 | Clinical Orthopaedics ... | 2.5K | ✕ |
| 8 | Mikroskopische Technik | 1948 | — | 2.3K | ✕ |
| 9 | Soft Tissue Tumors | 1985 | Plastic & Reconstructi... | 2.3K | ✕ |
| 10 | Kinase Mutations and Imatinib Response in Patients With Metast... | 2003 | Journal of Clinical On... | 2.3K | ✕ |
In the News
Artificial intelligence project for improved sarcoma diagnoses for patient benefit
The majority of the funding has been secured from UK Research and Innovation (UKRI) along with smaller grants from Tom Prince Cancer Trust, Skeletal Cancer Trust, Sarcoma UK, Chordoma UK and Bone...
$14.5 million will move research in sarcomas, bladder ...
Hospital, will co-lead a team focused on improving early detection and treatment for six types of sarcoma that affect children, adolescents and young adults.] Building on their previous breakthroug...
Sarcoma Foundation of America, Inc.
It looks like you were misusing this feature by going too fast. You’ve been temporarily blocked from using it. **Back * English (US) * Español * Français (France) * 中文(简体)
Terry Fox-funded researchers uncover the origin of an ...
Fox New Frontiers Program Project Grant (PPG), researchers at the University of British Columbia (UBC) have answered one of the biggest questions in the study of synovial sarcoma:*where does this c...
FDA Grants Fast Track Designation to ADCE-D01 for Soft ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to ADCE-D01 for the treatment of soft tissue sarcoma, according to a news release from Adcendo ApS.
Code & Tools
📊 Sarcoma Dashboard |Bachelor thesis project: Data quality dashboard for PROM & CROM datasets in sarcoma care at the Cantonal Hospital Lucerne|
MINDS is a framework designed to integrate multimodal oncology data. It queries and integrates data from multiple sources, including clinical data,...
This is the Github Repo to the research paper **"Deep learning for diagnosis and survival prediction in soft tissue sarcoma"** by Foersch et al. It...
## Repository files navigation # Automatic Segmentation of Soft Tissue Sarcoma (Kaggle Challenge) CT-scan images of patients with soft tissue sar...
Recent Preprints
Next-generation sequencing-based genomic profiling of ...
**Background:**Sarcomas are rare mesenchymal tumors classified into soft tissue (STS) and bone sarcomas. Despite advances in treatment, the 5-year survival rate for metastatic disease remains low. ...
Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe - PubMed
**Background:**Sarcomas comprise a heterogeneous group of malignant tumors of mesenchymal origin where diagnosis plays a crucial role in tailoring disease management and treatment. In this context,...
Diagnosis and Therapy of Soft Tissue Sarcomas
Soft tissue sarcomas are rare, heterogeneous tumors requiring management in expert, multidisciplinary reference centres. Early suspicion, appropriate imaging (MRI as first choice), and core needle ...
BC Cancer and UBC Push Boundaries in Sarcoma Research
With previous Terry Fox funding, the team developed a single test now used internationally to detect more than 50 types of sarcoma, replacing dozens of complex tests, reducing costs and dramaticall...
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines
multidisciplinary reference centres. Early suspicion, appropriate imaging (MRI as first choice), and core needle biopsy performed in referral centres are critical for diagnosis. Surgery with clear ...
Latest Developments
Recent developments in sarcoma diagnosis and treatment research include advancements presented at the 2026 ESMO Sarcoma and Rare Cancers Congress, focusing on molecular classification and personalized therapies (ESMO). Additionally, promising clinical trials are exploring immunotherapy combinations, ultrasound ablation, and novel gene therapies, such as FDA-approved gene therapy for metastatic synovial sarcoma as of February 2026 (UCSF trials, FDA). Furthermore, innovative approaches like immune-targeting vaccines and molecular research into oncogenesis are also shaping future strategies (MD Anderson, Nature Reviews Clinical Oncology, Nature).
Sources
Frequently Asked Questions
What staging system is used for musculoskeletal sarcoma?
Enneking et al. (1980) developed 'A System for the Surgical Staging of Musculoskeletal Sarcoma' that classifies tumors based on grade, site, and lymph node involvement to predict surgical outcomes. This system remains foundational for resection planning. It has 2465 citations reflecting its widespread use.
How does tumor size affect GIST prognosis?
DeMatteo et al. (2000) reported in 'Two Hundred Gastrointestinal Stromal Tumors' that tumor size predicts disease-specific survival in primary GISTs after complete gross resection. Recurrence is typically intraabdominal. The study of 200 cases has 2520 citations.
What role do kinase mutations play in GIST treatment?
Heinrich et al. (2003) showed in 'Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor' that KIT or PDGFRA mutations determine imatinib response in metastatic GIST. Mutant isoforms are therapeutic targets. The paper has 2279 citations.
What is the efficacy of larotrectinib in TRK fusion-positive cancers?
Drilon et al. (2018) demonstrated in 'Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children' that larotrectinib provides marked and durable antitumor activity across tumor types and ages. It applies to sarcomas with TRK fusions. The study has 2596 citations.
What diagnostic methods are recommended for soft tissue sarcomas?
Recent guidelines in 'Diagnosis and Therapy of Soft Tissue Sarcomas' emphasize MRI as the first-choice imaging, core needle biopsy in referral centers, and management in multidisciplinary centers. Surgery with clear margins is the cornerstone for localized disease. Radiotherapy and chemotherapy complement in selected cases.
Open Research Questions
- ? How can next-generation sequencing improve outcomes in metastatic sarcomas with low 5-year survival?
- ? What is the origin of synovial sarcoma, as explored in recent Terry Fox-funded research?
- ? Which kinase mutations beyond KIT/PDGFRA predict response to novel therapies in GIST?
- ? How do multimodal data integration systems enhance sarcoma diagnosis accuracy?
- ? What barriers limit NGS adoption in real-world sarcoma diagnostics across institutions?
Recent Trends
Preprints from the last six months emphasize NGS for sarcoma diagnostics, including genomic profiling and multi-institutional real-world data in Europe.
BC Cancer/UBC's Terry Fox-funded single test detects over 50 sarcoma types, replacing dozens of tests.
AI initiatives for improved diagnoses received UKRI funding, and FDA granted fast track to ADCE-D01 for soft tissue sarcoma.
Research Sarcoma Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Sarcoma Diagnosis and Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.